YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Injury Alerts
In order to make interested parties aware of breaking news regarding warnings, recalls or litigation matters, Parker Waichman Alonso LLP has created InjuryAlert, our proprietary e-newsletter written by our staff of attorneys. Click here to sign up for the newsletter.
ISSUES OF THE ELDERLY
Jul 1, 2005
IntroductionAs the first of the “baby boomers” reach 60, more and more attention is being focused on a growing number of issues affecting...
ANTIDEPRESSANTS ALTHOUGH THESE POWERFUL DRUGS SERVE A USEFUL PURPOSE, THEIR EXTREMELY SERIOUS SIDE-EFFECTS MUST NEVER BE MINIMIZED ZYPREXA SETTLEMENT UPDATE INFORMATION INCLUDED
Jun 1, 2005
IntroductionWhen Prozac was approved by the FDA in 1988, it immediately gave hope to millions of people who suffered from depression. As a result of...
IDENTITY THEFT SERIOUS SECURITY BREACHES AT MAJOR CORPORATIONS, FINANCIAL INSTITUTIONS, AND OTHER ORGANIZATIONS JEOPARDIZE THE PERSONAL INFORMATION OF COUNTLESS INDIVIDUALS
May 1, 2005
Introduction:In October 2002, we wrote about “identity theft” which was rapidly becoming a serious problem in this country and around the...
IN THE WORLD OF PRESCRIPTION DRUGS, EQUATING NEW WITH GOOD OR SAFE CAN BE HAZARDOUS TO YOUR HEALTH
Apr 1, 2005
Last month we focused on an array of prescription drugs (many in late-stage testing and some already on the market) which have shown promise in...
WILL THE NEW CROP OF DRUGS RESTORE A MEASURE OF CREDIBILITY TO THE PHARMACEUTICAL INDUSTRY OR MERELY EXPOSE THE PUBLIC TO ANOTHER ROUND OF RUSSIAN ROULETTE? (Part I Fifty Potential Successes)
Mar 1, 2005
Introduction:For the past several months, we have examined a number of problems associated with the pharmaceutical industry including: (a) several...
COX-2 INHIBITORS TO REMAIN ON THE MARKET: WHAT MESSAGE DOES THE QUESTIONABLE FDA VOTE SEND? (UPDATED)
Mar 1, 2005
*This email alert is being re-sent to include new information.*When the FDA announced it would hold hearings regarding the safety of COX-2...
DIRECT TO CONSUMER ADVERTISING: WHO THOUGHT THIS WAS A GOOD IDEA?
Feb 1, 2005
In our March/April 2002 Newsletter we discussed the ongoing debate surrounding the controversial methods being used by pharmaceutical manufacturers...
THE FDA UNDER FIRE: RECENT HIGH PROFILE DRUG WITHDRAWALS SERIOUSLY COMPROMISE THE AGENCY'S CREDIBILITY
Jan 1, 2005
[Also in this issue: PROZAC ALERT]Over four years ago, in our September 2000 Newsletter, we raised serious questions about the effectiveness and...
CHOLESTEROL DRUGS: THE RISKS VARY AS WIDELY AS THE CHOICES Part 2 - The Non-Statins
Dec 1, 2004
PART 2: The Non-StatinsIn last month's Newsletter, we provided our readers with a thorough discussion of cholesterol, trans fatty acids, and the...
CHOLESTEROL DRUGS: THE RISKS VARY AS WIDELY AS THE CHOICES Part 1 - The Statins
Nov 1, 2004
Introduction:Although more people worldwide suffer from high cholesterol than ever before, the problem has reached epidemic proportions in the United...
Case Review Form
